Home › NDC Lookup › RxCUI directory › RxCUI 197572

Desonide 0.5 MG/ML Topical Lotion — RxCUI 197572

RxNorm drug concept · Semantic clinical drug
RxCUI 197572 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197572
Official nameDesonide 0.5 MG/ML Topical Lotion
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdesonide 0.05 % Topical Lotion
FDA products mapped6
Package NDCs mapped11
Reported Medicaid activity (SDUD)2,507 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Desonide Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Desonide is a mild steroid cream or gel used to treat atopic dermatitis — what most people call eczema. It helps calm the redness, itching, and inflammation that come with flare-up...
  • Apply a thin layer to the affected area twice a day and gently rub it in. Less is more — you don't need to slather it on. Keep it away from your eyes and don't cover it with tight...
  • Most people just notice mild burning or stinging when they first apply it, and that usually fades. Some people get a little redness or itching at the site. The bigger concern with...
  • Are there any side effects I should watch for?
📖 Read our full Desonide Topical guide →

🕸️ Concept Web — How Desonide 0.5 MG/ML Topical Lotion Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Desonide 0.5 MG/ML Topical Lotion RxCUI 197572

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Desonide 3254
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Desowen 216501
    • Lokara 405178
  3. Dose forms 8

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Desonide Topical Lotion 378605
    • Desonide Topical Product 1154230
    • Desonide Topical Lotion [Desowen] 365703
    • Desonide Topical Lotion [Lokara] 584512
    • Desowen Topical Product 1174521
    • Lokara Topical Product 1179644
    • Topical Lotion 316983
    • Topical Product 1151122
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Desonide 0.5 MG/ML 328228
    • Desonide 0.5 MG/ML Topical Lotion [Desowen] 205534
    • Desonide 0.5 MG/ML Topical Lotion [Lokara] 584513
    • Desonide 0.5 MG/ML [Desowen] 566431
    • Desonide 0.5 MG/ML [Lokara] 584511

Showing up to 8 concepts per family — 16 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Desonide 0.5 MG/ML SCDC · 328228
  • Desonide Topical Lotion SCDF · 378605
  • Desonide Topical Product SCDG · 1154230

Brand-Name Concepts

  • Desonide 0.5 MG/ML Topical Lotion [Desowen] SBD · 205534
  • Desonide 0.5 MG/ML Topical Lotion [Lokara] SBD · 584513
  • Desonide 0.5 MG/ML [Desowen] SBDC · 566431
  • Desonide 0.5 MG/ML [Lokara] SBDC · 584511
  • Desonide Topical Lotion [Desowen] SBDF · 365703
  • Desonide Topical Lotion [Lokara] SBDF · 584512
  • Desowen Topical Product SBDG · 1174521
  • Lokara Topical Product SBDG · 1179644
  • Desowen BN · 216501
  • Lokara BN · 405178

📦 FDA Products & Package NDCs

6 products · 11 package NDCs
11 package NDCs map to RxCUI 197572 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00472-0803-02 1 BOTTLE in 1 CARTON (0472-0803-02) / 59 mL in 1 BOTTLE Desonide Actavis Pharma, Inc. 2009-05-28
00472-0803-04 1 BOTTLE in 1 CARTON (0472-0803-04) / 118 mL in 1 BOTTLE Desonide Actavis Pharma, Inc. 2009-05-28
00472-0804-15 1 TUBE in 1 CARTON (0472-0804-15) / 15 g in 1 TUBE Desonide Actavis Pharma, Inc. 2013-08-01
00472-0804-60 1 TUBE in 1 CARTON (0472-0804-60) / 60 g in 1 TUBE Desonide Actavis Pharma, Inc. 2013-08-01
46708-0550-18 1 BOTTLE in 1 CARTON (46708-550-18) / 118 mL in 1 BOTTLE Desonide Alembic Pharmaceuticals Limited 2025-03-26
46708-0550-59 1 BOTTLE in 1 CARTON (46708-550-59) / 59 mL in 1 BOTTLE Desonide Alembic Pharmaceuticals Limited 2025-03-26
51672-4079-04 1 BOTTLE in 1 CARTON (51672-4079-4) / 59 mL in 1 BOTTLE Desonide Taro Pharmaceuticals U.S.A., Inc. 2014-10-31
51672-4079-08 1 BOTTLE in 1 CARTON (51672-4079-8) / 118 mL in 1 BOTTLE Desonide Taro Pharmaceuticals U.S.A., Inc. 2014-10-31
62332-0550-18 1 BOTTLE in 1 CARTON (62332-550-18) / 118 mL in 1 BOTTLE Desonide Alembic Pharmaceuticals Inc. 2020-08-28
62332-0550-59 1 BOTTLE in 1 CARTON (62332-550-59) / 59 mL in 1 BOTTLE Desonide Alembic Pharmaceuticals Inc. 2020-08-28
63629-8739-01 1 BOTTLE in 1 CARTON (63629-8739-1) / 59 mL in 1 BOTTLE Desonide Bryant Ranch Prepack 2021-08-19
Observed labelers: Actavis Pharma, Inc. (4) · Alembic Pharmaceuticals Inc. (2) · Alembic Pharmaceuticals Limited (2) · Taro Pharmaceuticals U.S.A., Inc. (2) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.